U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 57

Tests names and labsConditionsGenes, analytes, and microbesMethods

F2 - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
41
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

F5 - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
51
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

F2 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
41
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

F5 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
51
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Pharmacogenomics Panel

Invitae
United States
4337
  • T Targeted variant analysis

Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel

PreventionGenetics
United States
340153
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Cerebral infarction, susceptibility to, 601367, Multifactorial (PRKCH gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Ischemic stroke, susceptibility to, 601367, Multifactorial (Early-onset autosomal dominant Alzheimer disease) (NOS3 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Stroke, ischemic, susceptibility to, 601367, Multifactorial (MLPA)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • D Deletion/duplication analysis

Stroke, susceptibility to, 601367, Multifactorial (ALOX5AP gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Stroke, ischemic, susceptibility to, 601367, Multifactorial (F2 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Stroke, ischemic, susceptibility to, 601367, Multifactorial (F5 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

F5 (Factor V) Leiden

Aventus Biolabs
United States
51
  • T Targeted variant analysis

F2 (Factor II)

Aventus Biolabs
United States
41
  • T Targeted variant analysis

Sport

Aventus Biolabs
United States
3621
  • T Targeted variant analysis

Health

Aventus Biolabs
United States
6130
  • T Targeted variant analysis

Estrogen

Aventus Biolabs
United States
1911
  • T Targeted variant analysis

RenalZoom

Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital
United States
525339
  • C Sequence analysis of the entire coding region

Thrombophilia, targeted F2, F5, MTHFR mutation testing

Genome Diagnostics Lab University Health Network
Canada
53
  • T Targeted variant analysis

Invitae Hereditary Thrombophilia Panel

Invitae
United States
2411
  • D Deletion/duplication analysis

Results: 1 to 20 of 57

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.